Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment

Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment

Triple-negative breast cancer (TNBC) is characterized by aggressive behavior and limited treatment options, necessitating the identification of novel therapeutic targets. In this study, we investigated the clinical significance of connective tissue growth factor (CTGF) as a prognostic marker and exp...

Full description

Bibliographic Details
Main Authors:	Jeong Hee Lee, Jongsu Kim, Hong Sook Kim, Young Jin Kang
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	International Journal of Molecular Sciences
Subjects:	connective tissue growth factor (CTGF) kahweol triple-negative breast cancer (TNBC)
Online Access:	https://www.mdpi.com/1422-0067/24/22/16307

Similar Items

Kahweol Exerts Skin Moisturizing Activities by Upregulating STAT1 Activity
by: Hongxi Chen, et al.
Published: (2021-08-01)

Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway
by: Hye-Young Seo, et al.
Published: (2021-09-01)

Kahweol, a Diterpenoid Molecule, Inhibits CTGF-Dependent Synthetic Phenotype Switching and Migration in Vascular Smooth Muscle Cells
by: Jeong Hee Lee, et al.
Published: (2021-01-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

Kahweol Ameliorates Cisplatin-Induced Acute Kidney Injury through Pleiotropic Effects in Mice
by: Jung-Yeon Kim, et al.
Published: (2020-12-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
by: Meng Wang, et al.
Published: (2021-10-01)

Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer
by: Fatma Al Qutami, et al.
Published: (2024-02-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
by: Dang Tan Nguyen, et al.
Published: (2021-07-01)

Coffee bean extracts rich and poor in kahweol both give rise to elevation of liver enzymes in healthy volunteers
by: Schouten Evert G, et al.
Published: (2004-07-01)

Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer
by: Efthymia Papakonstantinou, et al.
Published: (2022-08-01)

Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
by: Yaru Wang, et al.
Published: (2023-12-01)

New Achievements for the Treatment of Triple-Negative Breast Cancer
by: Alessia Catalano, et al.
Published: (2022-05-01)

Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)

Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
by: Ruoning Yang, et al.
Published: (2022-03-01)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01)

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01)

Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma
by: Lee Kyung-Ae, et al.
Published: (2012-06-01)

The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
by: Arianna Giacomini, et al.
Published: (2023-09-01)

The Coffee Diterpene, Kahweol, Ameliorates Pancreatic β-Cell Function in Streptozotocin (STZ)-Treated Rat INS-1 Cells through NF-kB and p-AKT/Bcl-2 Pathways
by: Waseem El-Huneidi, et al.
Published: (2021-08-01)

Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
by: Citra Dewi, et al.
Published: (2022-06-01)

Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
by: Xueqiong Xun, et al.
Published: (2022-07-01)

Association of FOSL1 copy number alteration and triple negative breast tumors
by: Leandro Tamião Rodrigues Serino, et al.
Published: (2019-02-01)

Kahweol, a coffee diterpene, increases lifespan via insulin/insulin-like growth factor-1 and AMP-activated protein kinase signaling pathways in Caenorhabditis elegans
by: Junhyo Cho, et al.
Published: (2023-01-01)

Expression of Circular RNA ciRS-7 and Its Effect on Invasion and Migration of Triple-negative Breast Cancer Cells
by: MENG Lingjiao, et al.
Published: (2019-03-01)

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
by: Luciana Molinero, et al.
Published: (2019-10-01)

Epidemiology, Pattern of Recurrence and Survival in Triple-negative Breast Cancer
by: Dharmendra Singh, et al.
Published: (2020-06-01)

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
by: Brahim El Hejjioui, et al.
Published: (2023-06-01)

Editorial: Targeting triple negative breast cancer by natural compounds
by: Shashank Kumar, et al.
Published: (2023-03-01)

Synergistic effects of combined cisplatin and Clinacanthus nutans extract on triple negative breast cancer cells
by: Nur Fitriyani Afiqah Binti Abu Bakar, MSc, et al.
Published: (2023-12-01)

Molecular Investigation on a Triple Negative Breast Cancer Xenograft Model Exposed to Proton Beams
by: Francesco P. Cammarata, et al.
Published: (2020-09-01)

ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
by: Alessandra Monaco, et al.
Published: (2021-09-01)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
by: Qiang Wu, et al.
Published: (2019-10-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
by: Hitesh Kumar, et al.
Published: (2023-12-01)

Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis
by: Neha Pathak, et al.
Published: (2022-08-01)

Cancer-Specific Outcomes in the Elderly with Triple-Negative Breast Cancer: A Systematic Review
by: Jenny Yoon, et al.
Published: (2021-06-01)

Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms
by: Shan-Ju Yeh, et al.
Published: (2021-03-01)

Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
by: Gaoming Liao, et al.
Published: (2022-02-01)

The functional role of Nudt2 in human triple negative breast cancer
by: Rasha Abu-Rahmah, et al.
Published: (2024-04-01)

KEY PLAYERS IN CHOLINE METABOLIC REPROGRAMMING IN TRIPLE NEGATIVE BREAST CANCER
by: Egidio Iorio, et al.
Published: (2016-09-01)